Altium Capital Management LP - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 63 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Altium Capital Management LP ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$3,071,000
+23.5%
625,469
+32.8%
0.81%
+39.7%
Q2 2021$2,487,000
+15.1%
470,949
+4.7%
0.58%
-3.8%
Q1 2021$2,160,000450,0000.60%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,423,578$8,826,0006.08%
Healthcare Value Capital, LLC 200,000$1,240,0002.33%
ARMISTICE CAPITAL, LLC 2,700,000$16,740,0001.06%
DELTEC ASSET MANAGEMENT LLC 550,836$3,415,0000.75%
Broadfin Capital, LLC 441,088$2,735,0000.60%
Kerrisdale Advisers, LLC 229,347$1,422,0000.51%
Worth Venture Partners, LLC 87,908$545,0000.30%
Mosaic Family Wealth, LLC 91,314$566,0000.24%
EMERALD ADVISERS, LLC 700,176$4,341,0000.17%
EMERALD MUTUAL FUND ADVISERS TRUST 616,664$3,823,0000.15%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders